List view / Grid view

Diabetes

 

news

FDA grants Priority Review for Lucentis in diabetic retinopathy

9 October 2014 | By Roche

Roche announced that the U.S. Food and Drug Administration has accepted to file the company's supplemental Biologics License Application and granted Priority Review of Lucentis (ranibizumab injection) for the treatment of diabetic retinopathy, an eye disease that impacts nearly 7.7 million Americans...

news

Mexico first country to launch Ryzodeg®

1 September 2014 | By Novo Nordisk

Novo Nordisk announced that in Mexico, as the first country in the world, Ryzodeg® is now launched and made available for people with type 2 diabetes...